Aurinia Pharmaceuticals (GB:0UJF)
LSE:0UJF

Aurinia Pharmaceuticals (GB:0UJF) Stock Price & Analysis

0 Followers

0UJF Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$15.41 - C$15.41
Previous CloseC$15.41
Volume0.00
Average Volume (3M)N/A
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$391.74M
Total Debt (Recent Filing)$8.38M
Price to Earnings (P/E)-14.6
Beta0.90
Next EarningsMar 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-1.05
Shares Outstanding128,225,927
R-Squared0.03
Standard Deviation0.34
10 Day Avg. Volume5,313
30 Day Avg. VolumeN/A
Price to Book (P/B)2.71
Price to Sales (P/S)29.13
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-12.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside2.26% Upside
Rating ConsensusStrong Buy
Alpha0.07
Number of Analyst Covering5


Financials

Annual

0UJF FAQ

What was Aurinia Pharmaceuticals’s price range in the past 12 months?
Aurinia Pharmaceuticals lowest stock price was C$15.41 and its highest was C$15.41 in the past 12 months.
    What is Aurinia Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Aurinia Pharmaceuticals’s upcoming earnings report date?
    Aurinia Pharmaceuticals’s upcoming earnings report date is Mar 09, 2023 which is in 41 days.
      How were Aurinia Pharmaceuticals’s earnings last quarter?
      Aurinia Pharmaceuticals released its earnings results on Nov 03, 2022. The company reported -C$0.08 earnings per share for the quarter, beating the consensus estimate of -C$0.309 by C$0.229.
        Is Aurinia Pharmaceuticals overvalued?
        According to Wall Street analysts Aurinia Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Aurinia Pharmaceuticals pay dividends?
          Aurinia Pharmaceuticals does not currently pay dividends.
          What is Aurinia Pharmaceuticals’s EPS estimate?
          Aurinia Pharmaceuticals’s EPS estimate is -C$0.36.
            How many shares outstanding does Aurinia Pharmaceuticals have?
            Aurinia Pharmaceuticals has 142,109,700 shares outstanding.
              What happened to Aurinia Pharmaceuticals’s price movement after its last earnings report?
              Aurinia Pharmaceuticals reported an EPS of -C$0.08 in its last earnings report, beating expectations of -C$0.309. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Aurinia Pharmaceuticals?
                Among the largest hedge funds holding Aurinia Pharmaceuticals’s share is Gilder Gagnon Howe & Co LLC.. It holds Aurinia Pharmaceuticals’s shares valued at 1M.

                  ---

                  Aurinia Pharmaceuticals Stock Smart Score

                  8
                  Outperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  The Aurinia Pharmaceuticals Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Aurinia Pharmaceuticals

                  Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases particularly lupus nephritis. The company was founded by Robert Foster, Richard Glickman and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Aurinia Pharmaceuticals
                  Repare Therapeutics
                  Zymeworks
                  Sernova
                  Xenon

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis